Journal article
Evaluating the Performance of the 2021 CKD-EPI Equation in People with Diabetes
Rodney Kwok, Richard Macisaac, Kartik Kishore, Tina Zafari, Mariam Hachem, Digsu Koye, Elke Schaeffner, Taedong Jeong, Won-Ki Min, Petter Bjornstad, Leonid Churilov, Elif I Ekinci
DIABETES | AMER DIABETES ASSOC | Published : 2024
DOI: 10.2337/db24-410-P
Abstract
Introduction: In 2021, CKD-EPI equation without the race coefficient (2021 CKD-EPI equation) was recommended for use in clinical practice by international guidelines. The performance of the 2021 equation in people with diabetes is unknown. This study aims to assess and compare the performance of the 2021 CKD-EPI equation to the 2009 CKD-EPI equation in individuals with type 1 and/or type 2 diabetes. Methods: Datapoints (n=16,182) were collected from people with type 1 and type 2 diabetes from six international cohorts (Diabetes Control and Complication Trial [DCCT, USA], Colorado [USA], Germany, Korea, Spain, and Australia), with mGFR assessed using exogenous filtration marker..
View full abstractGrants
Funding Acknowledgements
Australian Government Research Training Program (RTP) Scholarship